• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japane

tetano

Editor, Senior Moderator
J Infect Chemother. 2015 May 30. pii: S1341-321X(15)00124-5. doi: 10.1016/j.jiac.2015.05.004. [Epub ahead of print]
[h=1]In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.[/h] Ikematsu H[SUP]1[/SUP], Kawai N[SUP]2[/SUP], Iwaki N[SUP]2[/SUP], Kashiwagi S[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] To assess the extent of viral resistance, we measured the 50% inhibitory concentration (IC[SUB]50[/SUB]) of neuraminidase inhibitors (NAIs) for the influenza virus isolates in the 2013-2014 influenza season and compared the results to those of the 2010-2011 to 2012-2013 influenza seasons. Viral isolation was done with specimens obtained prior to treatment, and the type and subtype of influenza was determined by RT-PCR using type- and subtype-specific primers. The IC[SUB]50[/SUB] was determined by a neuraminidase inhibition assay using a fluorescent substrate. A total of 327 influenza viruses were isolated: 172 influenza A(H1N1)pdm09 (52.6%), 49 A(H3N2) (15.0%), and 106 B (32.4%). Numbers of Victoria and Yamagata lineage isolates were 36 and 70, respectively. Two A(H1N1)pdm09 isolates showed a high IC[SUB]50[/SUB] for oseltamivir (130 and 150 nM) exceeding by 100 times the geometric mean of the IC[SUB]50[/SUB] of oseltamivir for A(H1N1)pdm09 isolates (0.76 nM). No isolate showed a very high IC[SUB]50[/SUB] for A(H3N2) or B. The IC[SUB]50[/SUB] of the NAIs except for oseltamivir for A(H1N1) pdm09 were significantly higher than those of the 2010-2011 season (P < 0.05). The IC[SUB]50[/SUB] of all four NAIs for A(H3N2) were significantly lower than those of the 2012-2013 season (P < 0.001). The IC[SUB]50[/SUB] of the NAIs for B except for oseltamivir were significantly lower than those of the 2012-2013 season (P < 0.001). Although there are some isolates that show highly reduced sensitivity to oseltamivir among A(H1N1)pdm09 isolates, the currently epidemic influenza A(H1N1)pdm09, A(H3N2) and B viruses are susceptible to all four NAIs with no trend toward decreased sensitivity.
Copyright ? 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] 50% Inhibitory concentration; Influenza; Laninamivir; Oseltamivir; Peramivir; Zanamivir

PMID: 26096495 [PubMed - as supplied by publisher]
 
Back
Top Bottom